Who owns NEUBASE THERAPEUTICS INC?
- Ticker: NBSE
- CUSIP Number: 64132k201
Tip: Access positions for across all investors
Analyze quarterly positions in Neubase Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neubase Therapeutics stock
Who bought or sold NEUBASE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DME Capital Management | 136k | $61k | 100% | Mar 2024 |
|
| Greenlight Capital | 136k | $101k | 0% | Dec 2023 |
|
| Point72 Asset Management | 63k | $28k | 0% | Mar 2024 |
|
| Carnegie Mellon University | 47k | $21k | 0% | Mar 2024 |
|
| Vanguard Group | 19k | $8.5k | 0% | Mar 2024 |
|
| Kestra Advisory Services | 17k | $12k | -8% | Dec 2023 |
|
| Springbok Capital Management | 16k | $7.0k | 0% | Mar 2024 |
|
| Geode Capital Management | 16k | $6.8k | 0% | Mar 2024 |
|
| UBS Group | 4.1k | $1.8k | -94% | Mar 2024 |
|
| Tower Research Capital | 2.6k | $1.2k | 6% | Mar 2024 |
|
| Cubist Systematic Strategies | 1.3k | $562.950000 | 100% | Mar 2024 |
|
| Bank of America Corporation | 804.00 | $371.046000 | 0% | Mar 2024 |
|
| First Manhattan | 353.00 | $158.002800 | -50% | Mar 2024 |
|
| Royal Bank of Canada | 153.00 | $0 | -49% | Mar 2024 |
|
| Wells Fargo & Company | 79.00 | $34.760000 | 0% | Mar 2024 |
|
| Advisor Group Holdings | 22.00 | $9.999000 | 0% | Mar 2024 |
|
| Pnc Financial Services | 21.00 | $9.000600 | 0% | Mar 2024 |
|
| Newbridge Financial Services Group | 12.00 | $5.000400 | 0% | Mar 2024 |
|
| Morgan Stanley | 9.00 | $4.500000 | 0% | Mar 2024 |
|
Who sold out of Neubase Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Dec 2023 | 21k | $16k |
| BlackRock | Sep 2023 | 440.00 | $383.152000 |
| Global Wealth Management Investment Advisory | Dec 2023 | 12.00 | $9.000000 |